RANKL and OPG Polymorphisms Are Associated with Aromatase Inhibitor-Related Musculoskeletal Adverse Events in Chinese Han Breast Cancer Patients

Rheumatoid Arthritis: A Complication of Aromatase Inhibitor Therapy?

(2017) V. Bruzzese et al.   INTERNATIONAL JOURNAL OF IMMUNOPATHOLOGY AND PHARMACOLOGY

Patient-reported outcomes in women with breast cancer enrolled in a dual-center, double-blind, randomized controlled trial assessing the effect of acupuncture in reducing aromatase inhibitor-induced musculoskeletal symptoms

(2013) Ting Bao et al.   CANCER

Impact of BMI on serum estradiol and bone turnover markers in postmenopausal women with hormone-sensitive early breast cancer treated with anastrozole

(2013) I. Kyvernitakis et al.   JOURNAL OF CANCER RESEARCH AND CLINICAL ONCOLOGY

Acupuncture for treatment of arthralgia secondary to aromatase inhibitor therapy in women with early breast cancer: pilot study

(2013) B Oh et al.   Acupuncture in Medicine

Efficacy of zoledronic acid in postmenopausal Japanese women with early breast cancer receiving adjuvant letrozole: 12-month results

(2012) Shunji Takahashi et al.   BREAST CANCER RESEARCH AND TREATMENT

Fracture risk in women with breast cancer: A population-based study

(2012) L Joseph Melton et al.   JOURNAL OF BONE AND MINERAL RESEARCH

Osteocyte RANKL: New insights into the control of bone remodeling

(2012) Jinhu Xiong et al.   JOURNAL OF BONE AND MINERAL RESEARCH

Bench to bedside: elucidation of the OPG–RANK–RANKL pathway and the development of denosumab

(2012) David L. Lacey et al.   NATURE REVIEWS DRUG DISCOVERY

"Single nucleotide polymorphisms of the OPG/RANKL system genes in primary hyperparathyroidism and their relationship with bone mineral density"

(2011) María Piedra et al.   BMC Medical Genetics

Molecular Pathways: Osteoclast-Dependent and Osteoclast-Independent Roles of the RANKL/RANK/OPG Pathway in Tumorigenesis and Metastasis

(2011) W. C. Dougall   CLINICAL CANCER RESEARCH

A functional RANKL polymorphism associated with younger age at onset of rheumatoid arthritis

(2010) Wenfeng Tan et al.   ARTHRITIS AND RHEUMATISM

Inflammatory cytokines and aromatase inhibitor-associated musculoskeletal syndrome: a case–control study

(2010) N L Henry et al.   BRITISH JOURNAL OF CANCER

Genetic variation in the RANKL/RANK/OPG signaling pathway is associated with bone turnover and bone mineral density in men

(2010) Delnaz Roshandel et al.   JOURNAL OF BONE AND MINERAL RESEARCH

Effect of Endocrine Therapies on Bone in Breast Cancer Patients

(2010) R. J. Santen   JOURNAL OF CLINICAL ENDOCRINOLOGY & METABOLISM

Genome-Wide Associations and Functional Genomic Studies of Musculoskeletal Adverse Events in Women Receiving Aromatase Inhibitors

(2010) James N. Ingle et al.   JOURNAL OF CLINICAL ONCOLOGY

Effect of denosumab on bone mineral density in women receiving adjuvant aromatase inhibitors for non-metastatic breast cancer: subgroup analyses of a phase 3 study

(2009) Georgiana K. Ellis et al.   BREAST CANCER RESEARCH AND TREATMENT

Sonographic and Electrodiagnostic Evaluations in Patients With Aromatase Inhibitor–Related Arthralgia

(2009) Omer Dizdar et al.   JOURNAL OF CLINICAL ONCOLOGY

Gene–gene interactions in RANK/RANKL/OPG system influence bone mineral density in postmenopausal women

(2009) Janja Zupan et al.   JOURNAL OF STEROID BIOCHEMISTRY AND MOLECULAR BIOLOGY

Twenty bone-mineral-density loci identified by large-scale meta-analysis of genome-wide association studies

(2009) Fernando Rivadeneira et al.   NATURE GENETICS

Functions of RANKL/RANK/OPG in bone modeling and remodeling

(2008) Brendan F. Boyce et al.   ARCHIVES OF BIOCHEMISTRY AND BIOPHYSICS

Osteoprotegerin Lys3Asn Polymorphism and the Risk of Fracture in Older Women

(2008) S. P. Moffett et al.   JOURNAL OF CLINICAL ENDOCRINOLOGY & METABOLISM

Randomized Trial of Denosumab in Patients Receiving Adjuvant Aromatase Inhibitors for Nonmetastatic Breast Cancer

(2008) Georgiana K. Ellis et al.   JOURNAL OF CLINICAL ONCOLOGY

Late Extended Adjuvant Treatment With Letrozole Improves Outcome in Women With Early-Stage Breast Cancer Who Complete 5 Years of Tamoxifen

(2008) Paul E. Goss et al.   JOURNAL OF CLINICAL ONCOLOGY

Prospective Study to Assess Short-Term Intra-Articular and Tenosynovial Changes in the Aromatase Inhibitor–Associated Arthralgia Syndrome

(2008) Leilani Morales et al.   JOURNAL OF CLINICAL ONCOLOGY